Back to mobile site

Ziopharm Oncology (ZIOP) Tops Q4 EPS by 5c

February 26, 2015 5:11 PM EST

Ziopharm Oncology (NASDAQ: ZIOP) reported Q4 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Ziopharm Oncology (ZIOP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings